A 28-year-old woman from Mumbai presents with a 3-year history of recurrent itchy rashes on her hands, wrists, and face. She reports that symptoms worsen during winter and improve in summer. On examination, the affected areas show erythema, lichenification, and excoriations. She denies any contact with known irritants at work. Prick testing for common allergens is negative. Her 5-year-old daughter has similar skin lesions. Which of the following is the most important pathophysiological mechanism underlying her condition?

Explanation

## Clinical Diagnosis This patient has **atopic dermatitis (AD)** based on: - Chronic, relapsing course (3 years) - Pruritus-dominant presentation - Flexural and facial involvement - Lichenification (chronic scratching) - Seasonal pattern (worse in winter—dry air, low humidity) - Negative prick testing (rules out IgE-mediated contact allergy) - Family history of atopy (daughter affected) ## Pathophysiology of Atopic Dermatitis ### The Filaggrin Defect: Central Mechanism **High-Yield:** Loss-of-function mutations in the **FLG gene** (filaggrin) are the most important genetic risk factor for atopic dermatitis. Filaggrin is a key structural protein in the stratum corneum that: 1. **Aggregates keratin filaments** → maintains mechanical strength 2. **Breaks down into natural moisturizing factors (NMF)** → maintains hydration 3. **Maintains skin pH** → supports antimicrobial barrier ### Consequence: Impaired Barrier Function ```mermaid flowchart TD A[FLG mutation or reduced expression]:::outcome --> B[Decreased filaggrin protein]:::outcome B --> C[Defective stratum corneum structure]:::outcome C --> D[Increased transepidermal water loss TEWL]:::outcome D --> E[Dry skin xerosis]:::outcome E --> F[Increased penetration of irritants & allergens]:::action F --> G[Innate immune activation]:::action G --> H[Th2-skewed adaptive immunity]:::action H --> I[IL-4, IL-5, IL-13 production]:::outcome I --> J[IgE elevation & mast cell sensitization]:::outcome J --> K[Pruritus & inflammation]:::urgent ``` **Key Point:** The **"outside-in" hypothesis** of AD pathogenesis emphasizes that the primary defect is barrier dysfunction, not primary immune dysregulation. Barrier impairment allows allergen and irritant penetration, which then triggers secondary Th2 immune activation. ### Why Filaggrin Deficiency Explains This Patient's Features | Feature | Mechanism | |---------|----------| | Xerosis (dry skin) | Loss of NMF and increased TEWL | | Seasonal worsening | Low humidity in winter increases TEWL | | Pruritus | Irritant penetration; nerve fiber upregulation | | Lichenification | Chronic scratching response to barrier dysfunction | | Negative prick test | Primary defect is barrier, not IgE-mediated allergy | | Family history | FLG mutations are inherited (autosomal dominant) | ## Role of Secondary Immune Dysregulation **Clinical Pearl:** While filaggrin defects initiate AD, secondary Th2-skewed immune responses (elevated IgE, IL-4, IL-5) perpetuate inflammation. However, these are **consequences**, not the primary driver. ## Why NOT the Other Options? ### Option 1: IgE-Mediated Mast Cell Degranulation - **Trap:** AD does involve elevated IgE and mast cell involvement, but this is **secondary** to barrier dysfunction. - **Key distinction:** Prick testing is **negative**, indicating no IgE-mediated sensitization to common allergens. - The primary defect is barrier impairment, not allergic sensitization. ### Option 2: Delayed-Type Hypersensitivity (Contact Dermatitis) - **Trap:** AD can coexist with contact dermatitis, but the patient denies occupational exposure and has negative prick testing. - Contact dermatitis is a Th1-mediated response; AD is Th2-mediated. - The distribution (hands, wrists, face) and seasonal pattern fit AD, not occupational contact dermatitis. ### Option 3: Sebaceous Gland Dysfunction - **Trap:** AD is characterized by **lipid depletion** in the stratum corneum, but this is due to barrier defects (including filaggrin loss), not sebaceous gland pathology. - Sebaceous glands are not the primary source of stratum corneum lipids; they contribute to skin surface lipids. - This mechanism does not explain the genetic basis or family history. ## Clinical Implications **High-Yield:** Understanding filaggrin deficiency explains why AD management focuses on: - **Barrier repair:** Frequent emollients with ceramides, cholesterol, and free fatty acids (mimic healthy SC lipids) - **Avoiding irritants:** Harsh soaps, detergents worsen barrier dysfunction - **Topical corticosteroids:** Reduce secondary inflammation - **Calcineurin inhibitors:** Steroid-sparing option for maintenance [cite:Robbins & Cotran Pathologic Basis of Disease 10e Ch 25; Harrison's Principles of Internal Medicine 21e Ch 319]